Undisclosed CNS Therapeutic

About PassPort Technologies

PassPort Technologies is pioneering an active transdermal microporation platform designed to overcome the limitations of conventional drug patches. Its core technology painlessly creates microchannels in the skin's outer barrier, allowing for the delivery of larger molecules, including biologics and vaccines, via a simple patch. The company is leveraging the 505(b)(2) regulatory pathway for its lead preclinical CNS candidate and is pursuing partnerships to expand its pipeline. Its value proposition centers on needle-free administration, improved patient compliance, and potentially lower healthcare costs.

Therapeutic Areas